Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)

BC Reeves; W Underwood; HBC Cappel-Porter; SC Baos; CA Rogers; MA Arnott; SP Harding; U Chakravarthy; AE Foss

doi:10.1186/1745-6215-12-S1-A13

Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)

BC Reeves, W Underwood, HBC Cappel-Porter, SC Baos, CA Rogers, MA Arnott, SP Harding, U Chakravarthy, AE Foss

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Downloads (Pure)

Translated title of the contribution	Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
Original language	English
Article number	A13
Number of pages	1
Journal	Trials
Volume	12
Issue number	Suppl 1
DOIs	https://doi.org/10.1186/1745-6215-12-S1-A13
Publication status	Published - 13 Dec 2011

Research Groups and Themes

BTC (Bristol Trials Centre)

Access to Document

10.1186/1745-6215-12-S1-A13

Handle.net

Persistent link

1 Article (Academic Journal)

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration: One-Year Findings from the IVAN Randomized Trial
IVAN Study Investigators, Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J. & Wordsworth, S., Jul 2012, In: Ophthalmology. 119, 7, p. 1399-1411 13 p.
Research output: Contribution to journal › Article (Academic Journal) › peer-review
722 Citations (Scopus)

Cite this

Reeves, BC., Underwood, W., Cappel-Porter, HBC., Baos, SC., Rogers, CA., Arnott, MA., Harding, SP., Chakravarthy, U., & Foss, AE. (2011). Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD). Trials, 12(Suppl 1), Article A13. https://doi.org/10.1186/1745-6215-12-S1-A13

@article{1f6c3706577946ceb62173454d941c9a,

title = "Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)",

author = "BC Reeves and W Underwood and HBC Cappel-Porter and SC Baos and CA Rogers and MA Arnott and SP Harding and U Chakravarthy and AE Foss",

year = "2011",

month = dec,

day = "13",

doi = "10.1186/1745-6215-12-S1-A13",

language = "English",

volume = "12",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd",

number = "Suppl 1",

}

TY - JOUR

T1 - Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)

AU - Reeves, BC

AU - Underwood, W

AU - Cappel-Porter, HBC

AU - Baos, SC

AU - Rogers, CA

AU - Arnott, MA

AU - Harding, SP

AU - Chakravarthy, U

AU - Foss, AE

PY - 2011/12/13

Y1 - 2011/12/13

U2 - 10.1186/1745-6215-12-S1-A13

DO - 10.1186/1745-6215-12-S1-A13

M3 - Article (Academic Journal)

SN - 1745-6215

VL - 12

JO - Trials

JF - Trials

IS - Suppl 1

M1 - A13

ER -

Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)

Research Groups and Themes

Access to Document

Handle.net

Research output

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration: One-Year Findings from the IVAN Randomized Trial

Cite this